FAQ
Log In
Saturday 26th May 2018

Semaglutide Articles

1

Experimental drug could cut heart events in diabetics

19th September 2016

Study reveals experimental drug, semaglutide, reduces major cardiovascular events by 26%.

Read All ►

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018